Modella AI develops multimodal artificial intelligence models for biomedical imaging, focusing on pathology to integrate diverse biomarker data. This technology enhances diagnostic accuracy and therapeutic workflows, addressing the need for improved patient care in healthcare settings.
Funding
Funding not disclosed
Founders
Product
Problem
Pathologists face increasing workloads and complexity in analyzing biomedical images, requiring them to integrate diverse biomarker data for accurate diagnoses. Traditional methods can be time-consuming and subjective, potentially leading to diagnostic errors and delayed treatment. The need for efficient and objective tools to enhance diagnostic accuracy and therapeutic workflows is critical in modern healthcare settings.
Solution
Modella AI develops multimodal and generative AI copilots for pathology, designed to assist pathologists in analyzing biomedical images. Their AI models integrate diverse biomarker data, enhancing diagnostic, prognostic, and therapeutic workflows. The company offers PathChat, an AI copilot for consulting on pathology cases, which can summarize and create pathology reports from microscope images, slide viewers, or smartphones. Modella AI also provides Judith, an AI agent for automating AI model development for biomedical image analysis and scientific discovery.
Target Audience
The primary target audience includes pathologists, clinicians, and medical researchers involved in biomedical imaging analysis and diagnostic workflows.
Features
- Multimodal AI models that integrate diverse biomarker data from biomedical images.
- PathChat: An AI copilot for summarizing and creating pathology reports from various image sources.
- Judith: An AI agent for automating AI model development for biomedical image analysis.
- Generative AI capabilities for enhanced diagnostic and prognostic insights.